Chemokines: potent mediators of hepatic inflammation and fibrosis in chronic liver diseases
Journal Title: Annals of Hepatology - Year 2014, Vol 13, Issue 1
Abstract
Authors and Affiliations
Priya Handa, Kris V. Kowdley
Keywords
Related Articles
- EP ID EP78370
- DOI -
- Views 140
- Downloads 0
Pegylated interferon-alpha2b plus ribavirin for the treatment of chronic hepatitis C virus genotype 4 infection in patients with normal serum ALT
Background. Approximately one-third of patients with chronic hepatitis C virus infection have persistently normal liver enzymes reflected by a normal serum alanine transaminase (ALT). Data with regards the efficacy and s...
Transplanting Kidney Allografts from Hepatitis C Infected Donors into Hepatitis C Uninfected Recipients: Re-Thinking the Thinker Trial
In the not so distant past, organs from hepatitis C infected donors were either discarded or rarely transplanted into HCV viremic recipients - but never allocated to non-infected patients. However, the simplicity, ease...
Imaging surveillance and multidisciplinary review improves curative therapy access and survival in HCC patients
Introduction. Imaging surveillance and multidisciplinary conference (MDC) review can potentially improve survival in patients with hepatocellular carcinoma (HCC) by increasing access to liver transplantation. Geographic...
Role of nonalcoholic fatty liver disease in hepatocellular carcinoma
Obesity and related disorders are a common cause of morbidity worldwide. Nonalcoholic fatty liver disease is the most important hepatic consequence of adipose accumulation. There is strong evidence of obesity-related dis...
Acute hepatitis E mimicking a flare of disease in a patient with chronic autoimmune hepatitis
Acute hepatitis E is becoming increasingly recognised in Europe with up to 40% of the population in Southern France being exposed to the virus, which is harboured in pigs. Patients with known liver disease may present w...